Abstract
We tested the hypothesis that intensive (systolic blood pressure [SBP] <120 mmHg) rather than standard (SBP 130-139 mmHg) blood pressure (BP) control improves health-related quality of life (HRQL) in those with type 2 diabetes. Subjects were 1,028 ACCORD (Action to Control Cardiovascular Risk in Diabetes) BP trial HRQL substudy participants who completed baseline and one or more 12-, 36-, or 48-month HRQL evaluations. Multivariable linear regression assessed impact of BP treatment assignment on change in HRQL. Over 4.0 years of follow-up, no significant differences occurred in five of six HRQL measures. Those assigned to intensive (vs. standard) BP control had statistically significant worsening of the Medical Outcomes Study 36-item short-form health survey (SF36) physical component scores (-0.8 vs. -0.2; P = 0.02), but magnitude of change was not clinically significant. Findings persisted across all prespecified subgroups. Intensive BP control in the ACCORD trial did not have a clinically significant impact, either positive or negative, on depression or patient-reported HRQL.
References
Mar 1, 1993·Medical Care·C A McHorneyA E Raczek
Mar 24, 1997·Archives of Internal Medicine·R H GrimmP R Liebson
Apr 1, 1997·Diabetes Care·M Peyrot, R R Rubin
Nov 11, 1998·JAMA : the Journal of the American Medical Association·M A Testa, D C Simonson
Jul 2, 1999·Diabetes Care
Nov 24, 1999·JAMA : the Journal of the American Medical Association·R L SpitzerJ B Williams
Jun 15, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·José R BanegasFernando Rodríguez-Artalejo
Jul 12, 2007·The American Journal of Cardiology·UNKNOWN ACCORD Study GroupMark D Sullivan
Jul 12, 2007·The American Journal of Cardiology·Mark D SullivanUNKNOWN ACCORD Study Group
Jul 12, 2007·Diabetes Care·Elbert S HuangDavid O Meltzer
Sep 4, 2007·Lancet·Anushka PatelB Williams
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi
Nov 4, 2010·Journal of Hypertension·Daisson J TrevisolFlávio D Fuchs
Dec 15, 2011·Kidney International·Faramarz Ismail-BeigiUNKNOWN ACCORD Study Group
Citations
Apr 20, 2014·Current Diabetes Reports·Richard I G HoltSherita Hill Golden
Apr 15, 2014·Journal of the American Society of Hypertension : JASH·Michael J BurlaPhillip D Levy
Jul 26, 2014·Diabetes Care·Richard I G HoltSherita H Golden
Oct 26, 2013·Transplantation Proceedings·H J JeonJ Yang
Mar 23, 2018·Nature Reviews. Disease Primers·Suzanne OparilPaul K Whelton
May 18, 2016·Hypertension·Nathalie MoiseAndrew E Moran
Feb 1, 2020·International Journal of Clinical Practice·Jun-Sing WangWayne Huey-Herng Sheu
Jun 15, 2019·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Ruohua YanUNKNOWN CHIEF Research Group
Nov 30, 2019·Journal of the American Geriatrics Society·Dan R BerlowitzRonald I Shorr
May 28, 2020·Health and Quality of Life Outcomes·Yunying HouXiaohua Wang
Apr 29, 2015·Journal of Hypertension·Saverio Stranges, Richard P Donahue
Feb 6, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Kathryn Evans Kreider
Aug 29, 2019·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Benjamin Emmert-AronsonSteven Chen
Aug 24, 2017·The New England Journal of Medicine·Dan R BerlowitzUNKNOWN SPRINT Research Group
Mar 7, 2020·The Lancet. Diabetes & Endocrinology·Thomas T van SlotenCoen D A Stehouwer
May 25, 2021·The Cochrane Database of Systematic Reviews·Emma L CunninghamBernadette McGuinness